Results 21 to 30 of about 1,199,100 (293)

Biochemical Pharmacology of the Sigma-1 Receptor [PDF]

open access: yesMolecular Pharmacology, 2016
The sigma-1 receptor (S1R) is a 223 amino acid two transmembrane (TM) pass protein. It is a non-ATP-binding nonglycosylated ligand-regulated molecular chaperone of unknown three-dimensional structure. The S1R is resident to eukaryotic mitochondrial-associated endoplasmic reticulum and plasma membranes with broad functions that regulate cellular calcium
Uyen B, Chu, Arnold E, Ruoho
openaire   +2 more sources

Sigma-1 receptor agonists directly inhibit Nav1.2/1.4 channels.

open access: yesPLoS ONE, 2012
(+)-SKF 10047 (N-allyl-normetazocine) is a prototypic and specific sigma-1 receptor agonist that has been used extensively to study the function of sigma-1 receptors.
Xiao-Fei Gao   +4 more
doaj   +1 more source

Is the sigma-1 receptor a potential pharmacological target for cardiac pathologies? A systematic review

open access: yesInternational Journal of Cardiology: Heart & Vasculature, 2020
Sigma-1 receptors are ligand-regulated chaperone proteins, involved in several cellular mechanisms. The aim of this systematic review was to examine the effects that the sigma-1 receptor has on the cardiovascular system.
Rebecca Lewis   +4 more
doaj   +1 more source

Sigma-1 receptor expression in a subpopulation of lumbar spinal cord microglia in response to peripheral nerve injury

open access: yesScientific Reports, 2023
Sigma-1 Receptor has been shown to localize to sites of peripheral nerve injury and back pain. Radioligand probes have been developed to localize Sigma-1 Receptor and thus image pain source.
Ethan Schonfeld   +6 more
doaj   +1 more source

3D-QSAR and docking studies of pentacycloundecylamines at the sigma-1 (σ1) receptor [PDF]

open access: yes, 2013
Pentacycloundecylamine (PCU) derived compounds have been shown to be promising lead structures for the development of novel drug candidates aimed at a variety of neurodegenerative and psychiatric diseases.
Ablordeppey   +31 more
core   +1 more source

Defining the ligand-dependent proximatome of the sigma 1 receptor

open access: yesFrontiers in Cell and Developmental Biology, 2023
Sigma 1 Receptor (S1R) is a therapeutic target for a wide spectrum of pathological conditions ranging from neurodegenerative diseases to cancer and COVID-19. S1R is ubiquitously expressed throughout the visceral organs, nervous, immune and cardiovascular
Jing Zhao   +16 more
doaj   +1 more source

Sigma-1 Receptor Plays a Negative Modulation on N-type Calcium Channel

open access: yesFrontiers in Pharmacology, 2017
The sigma-1 receptor is a 223 amino acids molecular chaperone with a single transmembrane domain. It is resident to eukaryotic mitochondrial-associated endoplasmic reticulum and plasma membranes.
Kang Zhang   +7 more
doaj   +1 more source

Sigma-2 Receptor—A Potential Target for Cancer/Alzheimer’s Disease Treatment via Its Regulation of Cholesterol Homeostasis

open access: yesMolecules, 2020
The sigma receptors were classified into sigma-1 and sigma-2 receptor based on their different pharmacological profiles. In the past two decades, our understanding of the biological and pharmacological properties of the sigma-1 receptor is increasing ...
Kai Yang   +5 more
doaj   +1 more source

Regulating ankyrin dynamics: Roles of sigma-1 receptors [PDF]

open access: yesProceedings of the National Academy of Sciences, 2001
Ankyrin is a cytoskeletal adaptor protein that controls important cellular functions, including Ca 2+ efflux at inositol 1,4,5-trisphosphate receptors (IP 3 R) on the endoplasmic reticulum. The present study found that sigma-1 receptors (Sig-1R), unique endoplasmic reticulum proteins that
T, Hayashi, T P, Su
openaire   +2 more sources

Rapid reduction of sigma(1)-Receptor binding and F-18-FDG uptake in rat gliomas after in vivo treatment with doxorubicin [PDF]

open access: yes, 2007
sigma-Receptors are strongly overexpressed in most rodent and human tumors and are proliferation markers. To evaluate the potential of a radiolabeled sigma(1)-ligand for therapy monitoring, we compared early changes of C-11-1-(3,4-dimethoxyphenethyl)-4 ...
de Jong, Johan R.   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy